Jacob Plieth

@JacobPlieth

Journalist @ApexOnco. The Wolverine Of Biotech / Mr ASH. Interested in: oncology. Not interested in: what stock you bought today. My internal plan is as follows

London, UK apexonco.com Joined October 2012

283 Following 34K Followers 29K Posts

Latest posts 5

Jacob Plieth @JacobPlieth 2d

The $CADL headline that wrote itself @ApexOnco

Jacob Plieth @JacobPlieth 2d

This point seems especially pertinent today $CADL

Jacob Plieth @JacobPlieth Sep 11, 2025

"The comments about the SPA are also completely wrong and misleading, as Candel has strictly adhered to the agreement with the FDA and the SPA is intact"

From $CADL 14 Nov 2024 SEC filing
(8/8)

View quoted post on X

Jacob Plieth @JacobPlieth Nov 6

Stradbio (co-founder & CEO is ex-CMO of Seagen) quietly picked up two Seagen-originated ADCs that $PFE ditched this year. Via @ApexOnco -> apexonco.com/node/2469/

Jacob Plieth @JacobPlieth Nov 4

Quick reminder that $BMY is currently enrolling 1,319 patients into trials of imzokitug. #SITC26 authors prob happy because this is *only* monotherapy.

Spontonic @spontonic Nov 4

1/ #CCR8 We get a first blush look at BMS-986340 efficacy. Only 101 patients, "evaluated across multiple tumor types, including the post-ICI NSCLC expansion cohort, where clinical activity was observed (objective response rate: 15%)". Authors happy, I consider it to be failure.
View quoted post on X

Jacob Plieth @JacobPlieth Nov 4

I always love this time of year. #Esmo26 is over, and that means we only have #SITC26, #Targets26, #ASH26 & #SABCS26 to go before #JPM27 & #GI27 hit in January.